Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 9 - Drugs for disorders of the cardiovascular system
Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
01/2001
01/02/2001CA2183313C Novel indane-2-mercaptoacetylamide disulfide derivatives useful as inhibitors of enkephalinase
01/02/2001CA2174034C Novel tricyclic amides, processes for their preparation and the pharmaceutical compositions which contain them
01/02/2001CA2106172C Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the treatment of restenosis associated with coronary intervention
01/02/2001CA2054850C Cyclic imino derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
01/02/2001CA1341162C Sbustituted aminomethyltetralins and their heterocyclic analogues
01/02/2001CA1341159C Pure enantiomers of 4,5-disubstituted .alpha.-butyrolactams, process for their preparation, and their use
01/01/2001WO2001003645A2 Methods and apparatus for relieving headaches, rhinitis and other common ailments
12/2000
12/30/2000CA2313131A1 Compositions and treatment for diabetic complications
12/30/2000CA2313105A1 Treatment for diabetic complications
12/30/2000CA2313063A1 Combinations of aldose reductase inhibitors and selective cyclooxygenase-2 inhibitors
12/28/2000WO2000079003A1 Polymorphisms in the human hmg-coa reductase gene
12/28/2000WO2000078972A2 Regulation with binding cassette transporter protein abc1
12/28/2000WO2000078971A2 Atp binding cassette transporter protein abc1 popypeptides
12/28/2000WO2000078970A1 Nucleic and proteinic acids corresponding to human gene abc1
12/28/2000WO2000078953A2 Human transport proteins
12/28/2000WO2000078952A2 Human rna metabolism proteins (rmep)
12/28/2000WO2000078815A1 ANTI-αvβ3? RECOMBINANT HUMAN ANTIBODIES, NUCLEIC ACIDS ENCODING SAME AND METHODS OF USE
12/28/2000WO2000078812A1 Method and compounds for inhibiting activity of serine elastases
12/28/2000WO2000078794A1 Cysteinyl protease inhibitors
12/28/2000WO2000078789A1 Aromatic and heterocyclic derivatives of phytosterols and/or phytostanols for use in treating or preventing cardiovascular disease
12/28/2000WO2000078779A2 N-pyrazole a2a receptor agonists
12/28/2000WO2000078778A2 C-pyrazole a2a receptor agonists
12/28/2000WO2000078777A1 Propargyl phenyl ether a2a receptor agonists
12/28/2000WO2000078776A2 Thiophene a2a receptor agonists
12/28/2000WO2000078774A2 Induction of pharmacological stress with adenosine receptor agonists
12/28/2000WO2000078768A1 Potassium channel openers
12/28/2000WO2000078767A1 Thienopyrimidines as phosphodiesterase inhibitors
12/28/2000WO2000078765A2 CHROMENO[4,3,2-de]ISOQUINOLINES AS POTENT DOPAMINE RECEPTOR LIGANDS
12/28/2000WO2000078762A1 Indoloazepines as vasopressin receptor antagonists
12/28/2000WO2000078754A1 Thienylhydrazon with digitalis-like properties (positive inotropic effects)
12/28/2000WO2000078751A2 Compounds for use in treatment of neurological disorders
12/28/2000WO2000078750A1 New pharmaceutically active compounds
12/28/2000WO2000078747A1 Acylhydrazine derivatives, process for preparing the same and use thereof
12/28/2000WO2000078746A1 Antiviral agents
12/28/2000WO2000078744A1 Thiochroman derivatives against neurological disorders
12/28/2000WO2000078742A1 Chroman derivatives against neurological disorders
12/28/2000WO2000078736A1 1,4-diazacycloheptane derivatives as neuroprotective agents
12/28/2000WO2000078731A1 5-cyano-2-aminopyrimidine derivatives
12/28/2000WO2000078720A1 Novel dihydropyridine derivative
12/28/2000WO2000078719A1 Dihydropyridine derivative
12/28/2000WO2000078718A1 4-aminopiperidine derivatives of tetrahydronaphthalene, chromans and thiochromans
12/28/2000WO2000078716A1 α1B-ADRENERGIC RECEPTOR ANTAGONISTS
12/28/2000WO2000078697A2 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
12/28/2000WO2000078341A1 A method for the prophylaxis and/or treatment of medical disorders
12/28/2000WO2000078332A2 Fish serine proteinases and their pharmaceutical and cosmetic use
12/28/2000WO2000078330A2 Adenosine diphosphatase and activators thereof and their medical uses
12/28/2000WO2000078326A1 Method and composition for preventing or treating adverse physiological effects associated with cardiac disease
12/28/2000WO2000078324A1 The leaves of cajanus cajan(l.) millsp and extract, formulation and uses thereof
12/28/2000WO2000078323A1 A use of icariin in preparing the medicine for preventing and treating sexual disorder and vasoconstrictive diseases
12/28/2000WO2000078319A1 Dihydropyrazine derivatives as npy antagonists
12/28/2000WO2000078318A1 Medicinal composition for oral administration
12/28/2000WO2000078317A1 Integrin receptor antagonists
12/28/2000WO2000078313A1 Arylthiazolidinedione and aryloxazolidinedione derivatives
12/28/2000WO2000078297A2 Stable xylometazoline and oxymetazoline solution
12/28/2000WO2000078145A1 Macrophage scavenger receptor antagonists
12/28/2000WO2000078143A1 Method of increasing the content of flavonoids and phenolic substances in plants
12/28/2000WO2000078119A2 Cardiomyocytes with enhanced proliferative potential
12/28/2000WO2000061551A3 Pyrimidine-2-one derivatives as integrin receptor ligands
12/28/2000WO2000048625A3 Inhibitors for use in hemostasis and immune function
12/28/2000WO2000043495A3 33 human secreted proteins
12/28/2000WO2000034474A3 Growth factor homolog zvegf3
12/28/2000WO2000031093A3 Benzylglycosylamides as inhibitors of smooth muscle cell proliferation
12/28/2000WO1999052493A3 Compounds that inhibit the binding of integrins to their receptors
12/28/2000DE19929410A1 New octapepide compounds as alpha v beta 6 integrin inhibitors useful for treating and diagnosing heart disease, tumors, osteoporosis, fibrosis, inflammation, infection and psoriasis
12/28/2000DE19929076A1 New indanyl-substituted benzenesulfonamide derivatives, as potassium channel blockers useful as safe antiarrhythmic agents, e.g. for treating atrial fibrillation or flutter
12/28/2000DE19929065A1 Synergistic drug combination, especially for treating cardiovascular diseases associated with metabolic disorders, comprising bi- or tricyclic aza-heterocyclic MTP inhibitor and HMG-CoA reductase inhibitor
12/28/2000CA2383492A1 Acylhydrazine derivatives, their production and use
12/28/2000CA2377698A1 Dihydropyrazine derivatives as npy antagonists
12/28/2000CA2377357A1 Fish serine proteinases and their pharmaceutical and cosmetic use
12/28/2000CA2377288A1 Macrophage scavenger receptor antagonists
12/28/2000CA2377270A1 Cardiomyocytes with enhanced proliferative potential
12/28/2000CA2377246A1 Arylthiazolidinedione and aryloxazolidinedione derivatives
12/28/2000CA2376733A1 Aromatic and heterocyclic derivatives of phytosterols and/or phytostanols for use in treating or preventing cardiovascular disease
12/28/2000CA2376284A1 A method for the prophylaxis and/or treatment of medical disorders
12/28/2000CA2376155A1 Pharmaceutical composition for oral use
12/28/2000CA2376081A1 Cysteinyl protease inhibitors
12/28/2000CA2376077A1 Integrin receptor antagonists
12/28/2000CA2375781A1 Compositions and methods for increasing cholesterol efflux and raising hdl using atp binding cassette transporter protein abci
12/28/2000CA2375771A1 Nucleic and proteinic acids corresponding to human gen abc1
12/28/2000CA2375493A1 Human transport proteins
12/28/2000CA2375407A1 Rna metabolism proteins
12/28/2000CA2375396A1 High molecular weight primary aliphatic alcohols obtained from beeswax and pharmaceutical use thereof
12/28/2000CA2375282A1 Potassium channel openers
12/28/2000CA2375278A1 Thienopyrimidines
12/28/2000CA2375268A1 Indoloazepines as vasopressin receptor antagonists
12/28/2000CA2375236A1 Anti-alphavbeta3 recombinant human antibodies, nucleic acids encoding same and methods of use
12/28/2000CA2375229A1 Method and compounds for inhibiting activity of serine elastases
12/28/2000CA2375211A1 Antiviral agents
12/28/2000CA2375182A1 5-cyano-2-aminopyrimidine derivatives
12/28/2000CA2373497A1 Chromeno[4,3,2-de]isoquinolines as potent dopamine receptor ligands
12/28/2000CA2368099A1 Adenosine diphosphatase and activators thereof and their medical uses
12/28/2000CA2341542A1 .alpha.1b-adrenergic receptor antagonists
12/27/2000EP1063292A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof
12/27/2000EP1063291A2 DNA encoding human alpha 1 adrenergic receptors and uses thereof
12/27/2000EP1063235A1 Benzofurylpyrone derivatives
12/27/2000EP1063228A1 Cycloalkene derivatives, process for producing the same, and use
12/27/2000EP1062948A1 Remedies for cardiac dilastolic disorders
12/27/2000EP1062323A2 Methods of diagnosis and triage using cell activation measures
12/27/2000EP1062319A1 Vascular endothelial growth factor 2
12/27/2000EP1062264A2 Enzyme inhibitors
1 ... 1245 1246 1247 1248 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 ... 1595